Prognostic significance of midwall fibrosis in dilated cardiomyopathy
| Autor: | Tristan D.H. Brown, Jiten Morarji, Ravi Assomull, Francisco Alpendurada, Zohya Khalique, Marc R. Dweck, Kishen Morarji, Sanjay K Prasad, Emmanouil Liodakis, Ankur Gulati |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
Medicine(all)
medicine.medical_specialty lcsh:Diseases of the circulatory (Cardiovascular) system Radiological and Ultrasound Technology business.industry Dilated cardiomyopathy Disease musculoskeletal system medicine.disease Transplantation Fibrosis lcsh:RC666-701 Internal medicine medicine Cardiology Clinical endpoint cardiovascular system Oral Presentation Radiology Nuclear Medicine and imaging cardiovascular diseases Outcome data Cardiology and Cardiovascular Medicine business Ischemic heart Angiology |
| Zdroj: | Europe PubMed Central Journal of Cardiovascular Magnetic Resonance, Vol 14, Iss Suppl 1, p O6 (2012) Journal of Cardiovascular Magnetic Resonance |
| ISSN: | 1532-429X |
| DOI: | 10.1186/1532-429x-14-s1-o6 |
| Popis: | Methods Consecutive patients with DCM referred for CMR between 2002-2008 were prospectively enrolled. The diagnosis of DCM was made using clinical, CMR and coronary angiographic findings. Patients with ischemic heart disease, primary valvar disease and infiltrative CM were excluded. LGE-CMR at 1.5T (Siemens Sonata or Avanto, Germany) was performed in 2 phase-encoding directions. The presence of midwall LGE was determined by a specialist blinded to all outcome data. The primary endpoint was all-cause mortality. The secondary endpoint was a composite of cardiovascular (CV) mortality or cardiac transplantation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|